Themis Medicare's Stock Hits All-Time High, Outperforms Sector and Sensex

Themis Medicare, a smallcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high on September 26, 2024. The stock has been performing well in the market, with MarketsMOJO giving it a 'Hold' rating.

On September 26, the stock hit a new 52-week high of Rs.300.45, outperforming the sector by 0.48%. It has also been on a consecutive gain for the last 2 days, with a 10.05% increase in returns during this period. The stock has been trading at a steady price of 300.45 since its opening.

In terms of moving averages, Themis Medicare is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the stock's performance.

In the past year, Themis Medicare has shown a remarkable growth of 71.70%, outperforming the Sensex's performance of 29.27%. This showcases the company's strong performance and potential for growth in the pharmaceutical industry.

With its recent surge in stock price and positive performance, Themis Medicare is definitely a company to watch out for in the smallcap pharmaceutical sector. Investors may want to consider holding onto their stocks for now, as the company continues to show promising growth.